Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify virologic failure in patients receiving first-line antiretroviral therapy
- Describe the resistance consequences of failing a first-line boosted PI-based regimen
- Discuss the evidence-based selection of new antiretroviral regimens for patients failing first-line boosted PI-based therapy
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.